22nd Annual Pharmaceutical & Medical Device Compliance Congress

Special Closed-Door Session- Invitation Only

Chief Compliance Officer Round Table

Hosted by Pharmaceutical Compliance Forum

Tuesday, November 2, 2021 1:00-4:00pm

Please Note: Live Attendance Is Required. The Roundtable Will Not Be Recorded

Welcome- PCF Co-Chairs

1:00-1:10 pm

Joseph Zimmerman (Chair), Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals

Indrani Franchini, JD, Formerly Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals

Joshua Marks, JD, Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim

Margaret Sparks, JD, Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi

Ann Marie Tejcek, MA, Senior Director, Global Medical Strategy & Transformation Leader, Eli Lilly

Donna White, CCEP, Vice President, Compliance, Chiesi

Antitrust Admonition

Seth Lundy, JD, Partner, FDA and Life Sciences, King & Spalding

Open Forum with PhRMA and AdvaMed

1:10-1:50 pm

Julie Ritchie Wagner, JD, Assistant General Counsel, PhRMA

Nancy Schwalje Travis, MIA, Vice President, Global Compliance & Governance, AdvaMed

Ann-Marie Tejcek, MA- Senior Director, Global Medical Strategy & Transformation Leader, Eli Lilly

CCO Connection Program- Partner Experience

1:50-2:00 pm

Break

2:00-2:15 pm

The Pivotal Role of CCO’s in Fostering a Strong Culture of Inclusion, Trust, and Psychological Safety

1:10-1:50 pm

Michael R. Clarke, JD, CCEP, Vice President, Global Chief Compliance Officer, ConvaTec

Janet S. Holcombe, JD, Vice President, Chief Compliance and Privacy Officer, The Children’s Hospital of Philadelphia

Katherine A. Lawler, JD, Senior Vice President, Global Chief Ethics Officer, US Bank

Jill Fallows Macaluso, JD, Corporate Vice President, Chief Ethics, Compliance & Privacy Officer, Novo Nordisk

Kiley Smith Kelly, MBA, Partner/Principal, EY (Moderator)

“Evolving our Operating Model” Discussion Breakout

3:15-4:00 pm

Choice of one of the following:

  1. Managing Remote Teams
  2. Scope & Structure of the Compliance Function
  3. Ethics and Compliance – The Road Ahead

Optional networking opportunities continue in the breakout rooms after the meeting

Leave a Comment